Abstract

Mammalian thyroid hormone receptors (TRs) have multiple isoforms, including the bona fide receptors that bind T3 (TRα1, TRβ1 and TRβ2) and a non-hormone-binding variant, TRα2. Intriguingly, TRα2 is strongly expressed in the brain, where its mRNA levels exceed those of functional TRs. Ablation of TRα2 in mice results in over-expression of TRα1, and a complex phenotype with low levels of free T3 and T4, without elevated TSH levels, suggesting an alteration in the negative feedback at the hypothalamic-pituitary level. As the hypothesis of a potential TRH response defect has never been tested, we explored the functional role of TRα2 in negative feedback on transcription of hypothalamic thyrotropin, Trh. The in vivo transcriptional effects of TRα2 on hypothalamic Trh were analysed using an in vivo reporter gene approach. Effects on Trh-luc expression were examined to that of two, T3 positively regulated genes used as controls. Applying in vivo gene transfer showed that TRα2 over-expression in the mouse hypothαlamus abrogates T3-dependent repression of Trh and T3 activation of positively regulated promoters, blocking their physiological regulation. Surprisingly, loss of function studies carried out by introducing a shTRα2 construct in the hypothalamus also blocked physiological T3 dependent regulation. Thus, modulating hypothalamic TRα2 expression by either gain or loss of function abrogated T3 dependent regulation of Trh transcription, producing constant transcriptional levels insensitive to feedback. This loss of physiological regulation was reflected at the level of the endogenous Trh gene, were gain or loss of function held mRNA levels constant. These results reveal the as yet undescribed dominant negative role of TRα2 over TRα1 effect on hypothalamic Trh transcription.

Highlights

  • Thyroid hormone (TH) production is controlled by the hypothalamic peptide Thyrotropin Releasing Hormone (TRH)

  • To test whether TRa2 acts as a dominant-negative receptor on hypothalamic gene transcription in vivo, two reporter gene assays were carried out, using a positively T3 regulated promoter (ME-tkluc) and a negatively regulated one (Trh-luc). In both cases we compared the effects of TRa2 over-expression to those of TRa1 overexpression, the action of which being already well characterised on both promoters in vivo

  • When TRa2 was co-transfected with Malic Enzyme (ME)-tk-luc, transcription was blocked at the basal level seen in controls in the presence of T3

Read more

Summary

Introduction

Thyroid hormone (TH) production is controlled by the hypothalamic peptide Thyrotropin Releasing Hormone (TRH). T3 exerts negative feedback on Trh transcription mainly through the beta forms of the thyroid receptors (TRb1 and TRb2) [1,2]. Each gene gives rise to two major isoforms, respectively TRa1 and a2, and TRb1 and b2, by alternative splicing. Both RNA [6,7] and protein [8,9] for each isoform are found in the hypothalamic paraventricular nucleus (PVN), site of TRH regulation. As TRa2 can bind DNA, but not activate transcription, it has been suggested that TRa2 may act as a dominant-negative receptor. TRa2 is highly conserved in human, rat and mouse, but is absent in non mammalian vertebrates [19], suggesting an important function for this protein in mammals

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.